Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.96 USD | -1.07% | -0.43% | +16.11% |
05-08 | Oppenheimer Adjusts IDEAYA Biosciences Price Target to $53 From $50, Maintains Outperform Rating | MT |
05-07 | IDEAYA Biosciences Shares Fall After Q1 Loss | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.11% | 3.13B | |
+24.69% | 46.71B | |
+48.83% | 41.8B | |
-1.08% | 41.52B | |
-5.86% | 29.55B | |
+10.82% | 25.78B | |
-20.48% | 19.26B | |
+2.36% | 12.14B | |
-2.81% | 12.08B | |
+28.38% | 11.98B |
- Stock Market
- Equities
- IDYA Stock
- News IDEAYA Biosciences, Inc.
- RBC Adjusts IDEAYA Biosciences' Price Target to $43 From $36, Keeps Outperform Rating